Trials / Completed
CompletedNCT00719862
A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-036 in Patients With Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 481 (actual)
- Sponsor
- Meda Pharmaceuticals · Industry
- Sex
- Female
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The Purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo nasal spray | Placebo |
| DRUG | 0.15% azelastine hydrochloride Nasal Spray | 0.15% azelastine hydrochloride 822 mcg |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2008-07-22
- Last updated
- 2010-02-02
- Results posted
- 2010-01-28
Locations
34 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00719862. Inclusion in this directory is not an endorsement.